Pasar al contenido principal

Filtros

Evidencia

Manuales/Guías

Noticias

What are the benefits or risks of providing daily iron by mouth as tablets, capsules, or syrups to infants, children and adolescents (0–19 years of age) to prevent or treat anaemia (shortage of red blood cells) caused by iron deficiency?

Disponible también en

Key messages

  • Daily oral iron probably reduces the risk of iron-deficiency anaemia (IDA), but probably makes little to no difference to the risk of falling sick due to cough or difficulty breathing, respiratory illness, diarrhoea, or fever.

  • Iron supplementation with other vitamins and minerals compared with no treatment or placebo increases the height which is appropriate to infants', children and adolescents' growth.

  • More studies are needed in developed countries which look at safety issues, such as unwanted effects and complications.

What is iron-deficiency anaemia (IDA)?

Iron-deficiency anaemia (IDA) is a condition where the body does not have enough healthy red blood cells to carry oxygen to its tissues. It is often caused by a lack of iron in the diet, leading to symptoms like tiredness, weakness and poor development in children. It is a widespread global public health problem, and can affect about 40% of children up to five years old, of which about half have anaemia caused by lack of iron. It is often treated by people eating iron-rich foods or supplementing the diet with iron. It is particularly a problem for children because iron is needed for growth and development.

What did we want to find out?

We wanted to find out if giving children and adolescents (0 to 19 years) daily provision of iron by swallowing tablets, capsules, or syrups with added iron prevents or treats IDA and whether it has any unwanted effects.

What did we do?

We searched for studies looking at the impact of taking iron alone as a supplement or iron with other healthy supplements on children and adolescents. We combined the findings from these studies and evaluated the strength of the evidence, taking into account factors such as study design and sample size.

What did we find?

We included 114 studies with 50,325 children and adolescents taking place worldwide, with most in Asia (67 studies). Fifty studies looked at children under 5 years of age, but some included both children and adolescents. Most studies were funded by non-profit organisations, such as UNICEF (50 studies).

Studies compared daily iron:

  • to no treatment or a sham treatment (placebo) (89 studies);

  • combined with folic acid to folic acid (0 studies);

  • combined with folic acid to no treatment or placebo (11 studies);

  • combined with other vitamins or minerals compared to other vitamins or minerals without iron (25 studies);

  • combined with other vitamins or minerals compared to no treatment or placebo (13 studies; 2254 children).

Main results

Iron supplementation compared with no treatment or a sham treatment (89 studies):

  • Makes little to no difference to how tall children grow and the risk of falling sick from cough, fever, and respiratory illness, but probably reduces the risk of IDA.

  • Is unclear whether iron supplementation causes unwanted effects such as vomiting and diarrhoea, and the risk of constipation is very uncertain.

  • May reduce the risk of anaemia, ID, and increase the risk of discoloured stools, but this is uncertain.

Iron supplementation combined with folic acid compared to folic acid (0 studies):

  • We did not find any studies.

Iron and folic acid supplementation compared to no treatment or sham treatment (11 studies):

  • Makes little to no difference to the chance of falling sick, and it probably reduces the risk of ID and IDA, but the evidence for reducing the risk of anaemia is very uncertain.

Iron supplementation combined with other vitamins or minerals compared to other vitamins or minerals without iron (25 studies):

  • Makes little to no difference to how tall children grow and the risk of falling sick due to diarrhoea-related illnesses.

  • Probably reduces the risk of IDA but probably makes little to no difference to the risk of cough and respiratory-related illnesses.

  • May reduce the risk of anaemia, but this is very uncertain, and probably increases the risk of vomiting, especially among infants < 6 months of age.

Iron supplementation combined with other vitamins and minerals compared to no treatment or placebo (13 studies):

  • Increases age-appropriate linear growth and probably reduces the risk of ID.

  • May increase the risk of vomiting in very young babies, but may reduce the risk of IDA (1 study). The reduction in the risk of anaemia and the risk of falling sick due to cough, fever, respiratory and diarrhoea-related illnesses are very uncertain.

What are the limitations of the evidence?

Our confidence in the evidence varies from little to high because studies were conducted among different types of people or used different ways of delivering the treatment. Also, it is possible that people in the studies were aware of which treatment they were getting. Not all the studies provided data for all the results we were interested in.

How up to date is this review?

The evidence is current to January 2025.

Objetivos

To determine the benefits and harms of daily oral iron supplementation in infants, children and adolescents 0–19 years of age with or without anaemia caused by iron deficiency (IDA).

Métodos de búsqueda

We searched CENTRAL, MEDLINE, CINAHL, 16 additional databases, and two trial registries up to January 2025.

Conclusiones de los autores

Daily oral supplementation of iron alone, iron with FA, or iron with vitamins/minerals may result in a significant reduction of iron-deficiency anaemia across our target population with little to no difference in morbidity, and a probable increase in stool discolouration.

Financiación

Cornell Joan Klein Jacobs Center for Precision Nutrition and Health, Cornell University, (USA); World Health Organization (Switzerland)

Registro

Protocol (2018) DOI: https://doi.org/10.1002/14651858.CD013227

Referencia
Rajagopalan K, Hackl L, Peña-Rosas JP, Garcia-Casal MN, Rizal M, Mehta NH, Roudik M, Islam S, Trumbull-Kennedy MM, Khondakar NR, Franco JVA, Finkelstein JL, Mehta S. Daily iron supplementation for prevention or treatment of iron-deficiency anaemia in infants, children, and adolescents. Cochrane Database of Systematic Reviews 2026, Issue 11. Art. No.: CD013227. DOI: 10.1002/14651858.CD013227.pub2.

Nuestro uso de las cookies

Utilizamos las cookies necesarias para que nuestro sitio funcione. También nos gustaría establecer cookies analíticas opcionales para ayudarnos a mejorarla. No estableceremos cookies opcionales a menos que las habilite. El uso de esta herramienta establecerá una cookie en su dispositivo para recordar sus preferencias. Puede cambiar sus preferencias sobre las cookies en cualquier momento haciendo clic en el enlace "Configuración de las cookies" en el pie de cada página.
Si desea información más detallada acerca de las cookies que utilizamos, consulte nuestra página sobre Cookies.

Aceptar todo
Configurar